Table 2 Changes in the treatment during the follow-up
| Â | N (%) | Time from MTX onset (months)a | JADAS71 at the time of changea |
|---|---|---|---|
↑MTX dose | 18 (32.7) | 3.0 (3.0; 6.0) | 7.0 (4.5; 11.5) |
↓MTX dose | 20 (36.4) | 7.5 (6.0; 9.0) | 0.5 (0.0; 2.5) |
Change in route of administration | 13 (23.6) | 6.0 (4.0; 12.0) | 2.0 (0.4; 9.9) |
Withdrawal | 5 (9.1) | 9.0 (8.0; 9.0) | 3.0 (0.0; 6.5) |
Addition of biologic | 14 (25.5) | 3.8 (4.0; 8.8) | 15.8 (6.5; 13.0) |